
Veracyte Publishes First Studies Using Afirma GRID Tool
Landmark studies leverage Afirma GRID whole transcriptome-derived data to identify molecular classifiers and signatures differentiating thyroid cancer risk groups Veracyte, Inc. , a leading genomic diagnostics










